Project Grant R21AA031928

Award Date 8/8/24
Completion Date 7/31/26
Dollars Obligated $221K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
This Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), aims to investigate the role of alcohol metabolism and HIV infection in driving lung and liver multimorbidity through inter-organ crosstalk mediated by extracellular vesicles (EVs). The total funding amount is $148,449.00, with the award period spanning from September 17, 2024 to August 31, 2026. The principal investigator (PI) will conduct the...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $1,547,718 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) from September 1, 2024 to May 31, 2029. The project will investigate the role of KDM5 demethylases in regulating cell-cell communication in the development and resolution of alcohol-associated liver disease. Specifically, the research aims to determine how KDM5B and KDM5C...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $537,587 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The University of Texas Southwestern Medical Center to conduct research on the metabolic consequences of liver inflammation on alcohol consumption and alcohol-associated liver disease (ALD). The key objectives are to identify the mechanisms by which the transcription factor IRF3 suppresses the expression and secretion of the metabolic regulator...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under its Alcohol Research Programs (CFDA 93.273), awarded a $640,010 Project Grant to Vanderbilt University to conduct a 5-year study on the perceived norms around alcohol use and HIV/STI prevention among adolescents and young adults in rural Uganda. The study aims to: 1) use qualitative methods to explore perceived norms around alcohol, HIV/STI transmission risk, and HIV/STI prevention; 2) estimate the causal effects of...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $235,750 Project Grant (CFDA 93.273 - Alcohol Research Programs) to Rhode Island Hospital to study the detection and monitoring of alcohol-related white matter brain pathology. The project aims to leverage the hospital's existing bank of human alcohol use disorder (AUD) and control serum samples to characterize the effects of ethanol and different treatments on the expression of oligodendrocyte/myelin proteins,...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $1,345,684 Project Grant under CFDA 93.273 Alcohol Research Programs to the University of Colorado-Denver. The 5-year award, effective September 20, 2024, aims to determine the effects of alcohol use and sexual communication on intimate partner sexual violence (IPSV) among sexual minority and heterosexual couples. The project involves two studies: (1) a laboratory experiment examining acute alcohol use and partner sexual...
This federal Project Grant award of $380,863 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), supports research on the role of specific hepatic stellate cell subsets in the progression of alcohol-associated hepatitis (AH). The project aims to determine how the genes CYP1B1, PRRX1, and NR4A2 regulate the development and function of a novel FBLN2+ activated hepatic stellate cell (AHSC) subset in AH. Planned activities include...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the federal Alcohol Research Programs (CFDA 93.273), provides $698,356 to Brown University to study the relationship between alcohol-associated gut dysbiosis and cardiovascular disease (CVD) risk in people with HIV. The key objectives are to: 1) characterize alcohol-associated gut dysbiosis using whole genome sequencing of fecal samples; 2) examine how gut microbiome changes at the...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $330,829 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Board of Regents of the University of Nebraska, University of Nebraska Medical Center (UNMC) Division. The grant, titled "Leveraging Alcohol Use Disorder Screening for Treatment in Routine Perioperative Care: ALLUSCARE", aims to leverage existing electronic health record-integrated alcohol screening tools to increase the provision of...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $220,656 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division. The grant will fund research to investigate the effects of ethanol metabolism on the sorting of non-isgylated HIV proteins to hepatocyte-derived exosomes, and how these exosomes impact the pro-fibrotic activation of hepatic stellate cells. This research aims to elucidate the mechanisms of HIV-alcohol-induced liver fibrosis, which is a significant cause of morbidity and mortality among people living with HIV, particularly in the era of improved antiretroviral therapy. The project will utilize in vitro and in vivo approaches to provide insights that could lead to the development of therapeutic interventions to prevent liver disease progression in this patient population.

Generated 7/1/25, 2:14 AM